Close

Wockhardt gets US FDA nod to market Ceftazidime injections

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...
Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections. Ceftazidime is the generic name for the brand Fortaz, sold in the US by Glaxo Smithkline.

Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for marketing the injections containing 1 Gm/Vial Ceftazidime, which is used for treating various kinds of infections. Ceftazidime is the generic name for the brand Fortaz, sold in the US by Glaxo Smithkline.

Wockhardt Chairman Habil Khorakiwala said, Wockhardt is one of the only three companies to have received this approval. This product required significant R&D activity in both API and injections and is a reflection of the multi-faceted capabilities of Wockhardt to meet the challenges of the US markets.”Wockhardt’s Ceftazidime injections will be launched in the US very shortly.

Ceftazidime is used in treating several kinds of infections and is one of the most potent, powerful and safe antibiotics.The Ceftazidime pentahydrate API is manufactured in the FDA approved API facility at Ankleshwar, Gujarat and the injections are manufactured at the US FDA certified formulation plant at Waluj, Maharashtra. The API and the product were developed in-house.

Latest stories

Related stories

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back